AGA Center for Gut Microbiome Research & Education
Major programs
AGA Microbiome Update
Industry partners
For industries working in the microbiome space, the center can work with you to evaluate your product and help bring it to market.
AGA's Microbiome Center in the news
Dr. Phillip Tarr, chair of the AGA Center for Gut Microbiome Research & Education Scientific Advisory Board, comments on the significance of FDA’s approval of Rebyota to treat recurrent CDI.
Geoffrey Preidis, MD, PhD, speaks to CNN about AGA’s new clinical practice guidelines on probiotics for the management of GI diseases.
Alexander Khoruts, MD, provides perspective on AGA’s new clinical practice guidelines on probiotics.
Rob Knight, PhD, provides a new understanding of the way microbial populations shift with cancer could open a completely new therapeutic avenue.
Scientific Advisory Board
The mission of the AGA Center for Gut Microbiome Research and Education is to advance research and education on the gut microbiome with the goal of improving human health. To provide guidance on gut microbiome-related issues, AGA has convened a scientific advisory board comprised of world leaders in computational biology and metagenomics, microbiome animal models, microbiology translational research, nutrition, and pertinent regulatory and policy issues.
Phillip I. Tarr, MD (Chair)
Eugene B. Chang, MD, AGAF (Past-Chair)
Robert A. Britton, PhD
Geoffrey Preidis, MD, PhD
Diane Hoffman, JD, MS
Vanessa A. Leone, PhD
Rohit Loomba, MD
Ryan Ranallo, PhD
Alejandro Reyes, PhD
Siew Chien Ng, MD, PhD, AGAF
Elena F. Verdu, MD, PhD
Liping Zhao, PhD
Nicholas Davidson, MD, DSc, AGAF (Governing Board Liaison)
